{"id":4682,"date":"2018-07-04T18:40:13","date_gmt":"2018-07-04T16:40:13","guid":{"rendered":"https:\/\/www.hal-allergy.com\/?page_id=4682"},"modified":"2019-01-11T16:16:27","modified_gmt":"2019-01-11T15:16:27","slug":"news","status":"publish","type":"page","link":"https:\/\/www.hal-allergy.com\/at\/news\/","title":{"rendered":"News"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><section class=\"l-section wpb_row height_huge with_img\"><div class=\"l-section-img\" style=\"background-image: url(https:\/\/www.hal-allergy.com\/wp-content\/uploads\/2018\/07\/night_building_large_with-HALIX-e1530608884651.jpg);\" data-img-width=\"5564\" data-img-height=\"1488\"><\/div><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row type_default valign_top\"><div class=\"vc_col-sm-12 vc_hidden-lg vc_hidden-md vc_hidden-sm wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\"><div class=\"w-separator type_invisible size_large\"><\/div><div class=\"w-separator type_invisible size_large\"><\/div><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row height_medium\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row type_default valign_top\"><div class=\"vc_col-sm-12 wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\">\n\t<div class=\"wpb_text_column \">\n\t\t<div class=\"wpb_wrapper\">\n\t\t\t<h3><span style=\"color: #01478e;\">News<\/span><\/h3>\n<h5><span style=\"color: #01478e;\">Halten Sie sich auf dem Laufenden \u00fcber die neuesten Entwicklungen bei HAL Allergy\u00a0<\/span><\/h5>\n\n\t\t<\/div>\n\t<\/div>\n<\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row height_medium\" style=\"margin-top: -100px !important;\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row type_default valign_top\"><div class=\"vc_col-sm-12 wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\">\n\t<div class=\"wpb_text_column \">\n\t\t<div class=\"wpb_wrapper\">\n\t\t\t<style>.wp-show-posts-columns#wpsp-8347 {margin-left: -2em; }.wp-show-posts-columns#wpsp-8347 .wp-show-posts-inner {margin: 0 0 2em 2em; }<\/style><section id=\"wpsp-8347\" class=\" wp-show-posts\" style=\"\"><article class=\" wp-show-posts-single wpsp-clearfix post-16378 post type-post status-publish format-standard hentry category-uncategorized-at\" itemtype=\"http:\/\/schema.org\/CreativeWork\" itemscope><div class=\"wp-show-posts-inner\" style=\"\">\t\t\t\t\t\t<header class=\"wp-show-posts-entry-header\">\n\t\t\t\t\t\t\t<h5 class=\"wp-show-posts-entry-title\" itemprop=\"headline\"><a href=\"https:\/\/www.hal-allergy.com\/at\/2026\/07\/30\/hal-allergy-auf-kurs-fur-langfristiges-nachhaltiges-wachstum\/\" rel=\"bookmark\">HAL ALLERGY AUF KURS F\u00dcR LANGFRISTIGES, NACHHALTIGES WACHSTUM<\/a><\/h5>\t\t\t\t\t\t<\/header><!-- .entry-header -->\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"wp-show-posts-entry-summary\" itemprop=\"text\">\n\t\t\t\t\t\t\t<p>Leiden, Niederlande, D\u00fcsseldorf, Deutschland, Juli 2026 Im ersten Halbjahr 2026 erreichte HAL und sein Team mehrere Meilensteine: Kommerzielle Strategie liefert direkte Ergebnisse: Bereits im ersten Halbjahr 2026 wuchs der Umsatz&#8230;<\/p>\n\t\t\t\t\t\t<\/div><!-- .entry-summary -->\n\t\t\t\t\t<div class=\"wpsp-read-more\"><a title=\"HAL ALLERGY AUF KURS F\u00dcR LANGFRISTIGES, NACHHALTIGES WACHSTUM\" class=\"wp-show-posts-read-more\" href=\"https:\/\/www.hal-allergy.com\/at\/2026\/07\/30\/hal-allergy-auf-kurs-fur-langfristiges-nachhaltiges-wachstum\/\">Read more...<\/a><\/div><\/div><!-- wp-show-posts-inner --><div class=\"wpsp-clear\"><\/div><\/article><article class=\" wp-show-posts-single wpsp-clearfix post-16309 post type-post status-publish format-standard hentry category-uncategorized-at\" itemtype=\"http:\/\/schema.org\/CreativeWork\" itemscope><div class=\"wp-show-posts-inner\" style=\"\">\t\t\t\t\t\t<header class=\"wp-show-posts-entry-header\">\n\t\t\t\t\t\t\t<h5 class=\"wp-show-posts-entry-title\" itemprop=\"headline\"><a href=\"https:\/\/www.hal-allergy.com\/at\/2026\/06\/15\/neue-forschungsergebnisse-zu-hausstaubmilbenallergie-hal-allergy-schliest-grose-phase-iii-studie-ab\/\" rel=\"bookmark\">Neue Forschungsergebnisse zu Hausstaubmilbenallergie: \u2028HAL Allergy schlie\u00dft gro\u00dfe Phase-III-Studie ab<\/a><\/h5>\t\t\t\t\t\t<\/header><!-- .entry-header -->\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"wp-show-posts-entry-summary\" itemprop=\"text\">\n\t\t\t\t\t\t\t<p>Daten werden zust\u00e4ndigen Beh\u00f6rden und der Fachwelt zur Bewertung vorgelegt Leiden, Niederlande, D\u00fcsseldorf, Deutschland, 15. Juni 2026 \u2013 Hausstaubmilbenallergie geh\u00f6rt zu den h\u00e4ufigsten Ursachen f\u00fcr chronischen allergischen Schnupfen und kann&#8230;<\/p>\n\t\t\t\t\t\t<\/div><!-- .entry-summary -->\n\t\t\t\t\t<div class=\"wpsp-read-more\"><a title=\"Neue Forschungsergebnisse zu Hausstaubmilbenallergie: \u2028HAL Allergy schlie\u00dft gro\u00dfe Phase-III-Studie ab\" class=\"wp-show-posts-read-more\" href=\"https:\/\/www.hal-allergy.com\/at\/2026\/06\/15\/neue-forschungsergebnisse-zu-hausstaubmilbenallergie-hal-allergy-schliest-grose-phase-iii-studie-ab\/\">Read more...<\/a><\/div><\/div><!-- wp-show-posts-inner --><div class=\"wpsp-clear\"><\/div><\/article><article class=\" wp-show-posts-single wpsp-clearfix post-14955 post type-post status-publish format-standard hentry category-uncategorized-at\" itemtype=\"http:\/\/schema.org\/CreativeWork\" itemscope><div class=\"wp-show-posts-inner\" style=\"\">\t\t\t\t\t\t<header class=\"wp-show-posts-entry-header\">\n\t\t\t\t\t\t\t<h5 class=\"wp-show-posts-entry-title\" itemprop=\"headline\"><a href=\"https:\/\/www.hal-allergy.com\/at\/2025\/03\/19\/hal-allergy-announces-dr-philip-boehme-as-new-ceo-as-of-april-1st\/\" rel=\"bookmark\">HAL Allergy announces Dr. Philip Boehme as new CEO as of April 1st<\/a><\/h5>\t\t\t\t\t\t<\/header><!-- .entry-header -->\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"wp-show-posts-entry-summary\" itemprop=\"text\">\n\t\t\t\t\t\t\t<p>Leiden (The Netherlands, 19.03.2025) &#8211; As of April 1st, Dr. Philip Boehme, a medical doctor, chemical engineer and scientist, will join HAL Allergy as CEO, bringing in his deep R&amp;D&#8230;<\/p>\n\t\t\t\t\t\t<\/div><!-- .entry-summary -->\n\t\t\t\t\t<div class=\"wpsp-read-more\"><a title=\"HAL Allergy announces Dr. Philip Boehme as new CEO as of April 1st\" class=\"wp-show-posts-read-more\" href=\"https:\/\/www.hal-allergy.com\/at\/2025\/03\/19\/hal-allergy-announces-dr-philip-boehme-as-new-ceo-as-of-april-1st\/\">Read more...<\/a><\/div><\/div><!-- wp-show-posts-inner --><div class=\"wpsp-clear\"><\/div><\/article><article class=\" wp-show-posts-single wpsp-clearfix post-14817 post type-post status-publish format-standard hentry category-uncategorized-at\" itemtype=\"http:\/\/schema.org\/CreativeWork\" itemscope><div class=\"wp-show-posts-inner\" style=\"\">\t\t\t\t\t\t<header class=\"wp-show-posts-entry-header\">\n\t\t\t\t\t\t\t<h5 class=\"wp-show-posts-entry-title\" itemprop=\"headline\"><a href=\"https:\/\/www.hal-allergy.com\/at\/2024\/12\/19\/dr-werner-lanthaler-zum-vorsitzenden-des-aufsichtsrats-von-hal-allergy-ernannt\/\" rel=\"bookmark\">Dr. Werner Lanthaler zum Vorsitzenden des Aufsichtsrats von HAL Allergy ernannt<\/a><\/h5>\t\t\t\t\t\t<\/header><!-- .entry-header -->\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"wp-show-posts-entry-summary\" itemprop=\"text\">\n\t\t\t\t\t\t\t<p>Leiden, Niederlande, 18. Dezember 2024 &#8211; Dr. Werner Lanthaler ist neuer Vorsitzender des Aufsichtsrats von HAL Allergy. Dr. Werner Lanthaler verf\u00fcgt \u00fcber mehr als zwei Jahrzehnte Erfahrung in der Biotechnologie-&#8230;<\/p>\n\t\t\t\t\t\t<\/div><!-- .entry-summary -->\n\t\t\t\t\t<div class=\"wpsp-read-more\"><a title=\"Dr. Werner Lanthaler zum Vorsitzenden des Aufsichtsrats von HAL Allergy ernannt\" class=\"wp-show-posts-read-more\" href=\"https:\/\/www.hal-allergy.com\/at\/2024\/12\/19\/dr-werner-lanthaler-zum-vorsitzenden-des-aufsichtsrats-von-hal-allergy-ernannt\/\">Read more...<\/a><\/div><\/div><!-- wp-show-posts-inner --><div class=\"wpsp-clear\"><\/div><\/article><article class=\" wp-show-posts-single wpsp-clearfix post-14399 post type-post status-publish format-standard hentry category-uncategorized-at\" itemtype=\"http:\/\/schema.org\/CreativeWork\" itemscope><div class=\"wp-show-posts-inner\" style=\"\">\t\t\t\t\t\t<header class=\"wp-show-posts-entry-header\">\n\t\t\t\t\t\t\t<h5 class=\"wp-show-posts-entry-title\" itemprop=\"headline\"><a href=\"https:\/\/www.hal-allergy.com\/at\/2024\/03\/22\/die-lieferungen-wurden-erfolgreich-wiederaufgenommen\/\" rel=\"bookmark\">Die Lieferungen wurden erfolgreich wiederaufgenommen<\/a><\/h5>\t\t\t\t\t\t<\/header><!-- .entry-header -->\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"wp-show-posts-entry-summary\" itemprop=\"text\">\n\t\t\t\t\t\t\t<p>Nach dem Ransomware-Angriff vom 19. Februar wurden mehrere IT-Systeme von HAL Allergy wiederhergestellt. Die wiederhergestellten Systeme wurden in den letzten Wochen schrittweise aktiviert, um Lieferungen an die meisten unserer Kunden&#8230;<\/p>\n\t\t\t\t\t\t<\/div><!-- .entry-summary -->\n\t\t\t\t\t<div class=\"wpsp-read-more\"><a title=\"Die Lieferungen wurden erfolgreich wiederaufgenommen\" class=\"wp-show-posts-read-more\" href=\"https:\/\/www.hal-allergy.com\/at\/2024\/03\/22\/die-lieferungen-wurden-erfolgreich-wiederaufgenommen\/\">Read more...<\/a><\/div><\/div><!-- wp-show-posts-inner --><div class=\"wpsp-clear\"><\/div><\/article><article class=\" wp-show-posts-single wpsp-clearfix post-14283 post type-post status-publish format-standard hentry category-uncategorized-at\" itemtype=\"http:\/\/schema.org\/CreativeWork\" itemscope><div class=\"wp-show-posts-inner\" style=\"\">\t\t\t\t\t\t<header class=\"wp-show-posts-entry-header\">\n\t\t\t\t\t\t\t<h5 class=\"wp-show-posts-entry-title\" itemprop=\"headline\"><a href=\"https:\/\/www.hal-allergy.com\/at\/2024\/02\/22\/benachrichtigungserklarung\/\" rel=\"bookmark\">BENACHRICHTIGUNGSERKL\u00c4RUNG<\/a><\/h5>\t\t\t\t\t\t<\/header><!-- .entry-header -->\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"wp-show-posts-entry-summary\" itemprop=\"text\">\n\t\t\t\t\t\t\t<p>Cyber-Sicherheitsvorfall bei dem Allergen-Immuntherapie-Hersteller und -Lieferanten HAL Allergy B.V. Am Morgen des 19. Februar 2024 wurde HAL Allergy von einem Ransomware-Angriff heimgesucht. HAL Allergy beauftragte sofort externe Cybersicherheitsexperten, die bei&#8230;<\/p>\n\t\t\t\t\t\t<\/div><!-- .entry-summary -->\n\t\t\t\t\t<div class=\"wpsp-read-more\"><a title=\"BENACHRICHTIGUNGSERKL\u00c4RUNG\" class=\"wp-show-posts-read-more\" href=\"https:\/\/www.hal-allergy.com\/at\/2024\/02\/22\/benachrichtigungserklarung\/\">Read more...<\/a><\/div><\/div><!-- wp-show-posts-inner --><div class=\"wpsp-clear\"><\/div><\/article><article class=\" wp-show-posts-single wpsp-clearfix post-13856 post type-post status-publish format-standard hentry category-uncategorized-at\" itemtype=\"http:\/\/schema.org\/CreativeWork\" itemscope><div class=\"wp-show-posts-inner\" style=\"\">\t\t\t\t\t\t<header class=\"wp-show-posts-entry-header\">\n\t\t\t\t\t\t\t<h5 class=\"wp-show-posts-entry-title\" itemprop=\"headline\"><a href=\"https:\/\/www.hal-allergy.com\/at\/2021\/07\/08\/alex-huybens-appointed-as-chief-executive-officer-ceo-of-hal-allergy-holding-b-v-and-halix-b-v\/\" rel=\"bookmark\">Alex Huybens appointed as Chief Executive Officer (CEO) of HAL Allergy Holding B.V. and HALIX B.V.<\/a><\/h5>\t\t\t\t\t\t<\/header><!-- .entry-header -->\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"wp-show-posts-entry-content\" itemprop=\"text\">\n\t\t\t\t\t\t\t<p><em>Leiden (The Netherlands, 01.07.<\/em><em>2021)<\/em> \u2013 As of 1 July 2021, the Supervisory Board of the HAL Allergy Group has appointed Alex Huybens as Chief Executive Officer (CEO) and Member of the Board of HAL Allergy Holding B.V., as well as CEO of HALIX B.V.<\/p>\n\t\t\t\t\t\t<\/div><!-- .entry-content -->\n\t\t\t\t\t<div class=\"wpsp-read-more\"><a title=\"Alex Huybens appointed as Chief Executive Officer (CEO) of HAL Allergy Holding B.V. and HALIX B.V.\" class=\"wp-show-posts-read-more\" href=\"https:\/\/www.hal-allergy.com\/at\/2021\/07\/08\/alex-huybens-appointed-as-chief-executive-officer-ceo-of-hal-allergy-holding-b-v-and-halix-b-v\/\">Read more...<\/a><\/div><\/div><!-- wp-show-posts-inner --><div class=\"wpsp-clear\"><\/div><\/article><article class=\" wp-show-posts-single wpsp-clearfix post-8921 post type-post status-publish format-standard hentry category-uncategorized-at\" itemtype=\"http:\/\/schema.org\/CreativeWork\" itemscope><div class=\"wp-show-posts-inner\" style=\"\">\t\t\t\t\t\t<header class=\"wp-show-posts-entry-header\">\n\t\t\t\t\t\t\t<h5 class=\"wp-show-posts-entry-title\" itemprop=\"headline\"><a href=\"https:\/\/www.hal-allergy.com\/at\/2018\/08\/14\/als-erstes-unternehmen-hat-hal-allergy-zulassungen-unter-der-therapieallergene-verordnung-tav-in-deutschland-erhalten\/\" rel=\"bookmark\">Als erstes Unternehmen hat HAL Allergy Zulassungen unter der Therapieallergene-Verordnung (TAV) in Deutschland erhalten<\/a><\/h5>\t\t\t\t\t\t<\/header><!-- .entry-header -->\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"wp-show-posts-entry-content\" itemprop=\"text\">\n\t\t\t\t\t\t\t<h5>Zulassung der sublingualen Immuntherapie mit Birken- und Baumpollen in Deutschland<\/h5>\n<p>D\u00fcsseldorf (14. August 2018) \u2013 Die HAL Allergie Handels-GmbH gab heute die Zulassung der neuen sublingualen Birken- und Baumpollenprodukte bekannt. Dies sind die ersten Zulassungen durch das Paul-Ehrlich-Institut unter der deutschen Therapieallergene-Verordnung, die am 14. November 2008 in Kraft getreten ist.<\/p>\n\t\t\t\t\t\t<\/div><!-- .entry-content -->\n\t\t\t\t\t<div class=\"wpsp-read-more\"><a title=\"Als erstes Unternehmen hat HAL Allergy Zulassungen unter der Therapieallergene-Verordnung (TAV) in Deutschland erhalten\" class=\"wp-show-posts-read-more\" href=\"https:\/\/www.hal-allergy.com\/at\/2018\/08\/14\/als-erstes-unternehmen-hat-hal-allergy-zulassungen-unter-der-therapieallergene-verordnung-tav-in-deutschland-erhalten\/\">Read more...<\/a><\/div><\/div><!-- wp-show-posts-inner --><div class=\"wpsp-clear\"><\/div><\/article><\/section><!-- .wp-show-posts -->\n\n\t\t<\/div>\n\t<\/div>\n<\/div><\/div><\/div><\/div><\/div><\/section>\n<\/div>","protected":false},"excerpt":{"rendered":"Zulassung der sublingualen Immuntherapie mit Birken- und Baumpollen in Deutschland D\u00fcsseldorf (14. August 2018) \u2013 Die HAL Allergie Handels-GmbH gab heute die Zulassung der neuen sublingualen Birken- und Baumpollenprodukte bekannt. Dies sind die ersten Zulassungen durch das Paul-Ehrlich-Institut unter der deutschen Therapieallergene-Verordnung, die am 14. November 2008 in Kraft getreten ist. Die Therapieallergene-Verordnung wurde vom...","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_exactmetrics_skip_tracking":false,"footnotes":""},"class_list":["post-4682","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.hal-allergy.com\/at\/wp-json\/wp\/v2\/pages\/4682","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hal-allergy.com\/at\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.hal-allergy.com\/at\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.hal-allergy.com\/at\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hal-allergy.com\/at\/wp-json\/wp\/v2\/comments?post=4682"}],"version-history":[{"count":5,"href":"https:\/\/www.hal-allergy.com\/at\/wp-json\/wp\/v2\/pages\/4682\/revisions"}],"predecessor-version":[{"id":10300,"href":"https:\/\/www.hal-allergy.com\/at\/wp-json\/wp\/v2\/pages\/4682\/revisions\/10300"}],"wp:attachment":[{"href":"https:\/\/www.hal-allergy.com\/at\/wp-json\/wp\/v2\/media?parent=4682"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}